Início › Câncer de Pulmão › Kentucky

Ensaios clínicos de Câncer de Pulmão em Kentucky

26 estudos para Câncer de Pulmão estão buscando participantes em locais em Kentucky.

Cidades em Kentucky

Texto oficial do estudo (Inglês)

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Baptist Health Corbin, Corbin
Baptist Health Hardin, Elizabethtown
Baptist Health Lexington, Lexington
e mais 3

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT04267848

Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)

University of Kentucky Chandler Medical Center ( Site 0019), Lexington

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT06780098

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

CommonSpirit Saint Joseph Hospital - Bardstown, Bardstown
Commonwealth Cancer Center-Corbin, Corbin
Saint Elizabeth Healthcare Edgewood, Edgewood
e mais 5

RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos

Idades de 40 a 75 · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT05334069

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

University of Kentucky/Markey Cancer Center, Lexington
The James Graham Brown Cancer Center at University of Louisville, Louisville
UofL Health Medical Center Northeast, Louisville

RecrutandoFase 3

Idades 70 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT06096844

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

Saint Elizabeth Medical Center Edgewood-Cancer Care Center ( Site 0061), Edgewood

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06312137

A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion

Baptist Health Lexington, Lexington
University of Kentucky Chandler Medical Center, Lexington

RecrutandoFase 2/3

Idades 18 e acima · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT07063745

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

Baptist Health Hardin, Elizabethtown
Baptist Health Lexington, Lexington
University of Kentucky Chandler Medical Center (UKCMC) - Markey Cancer Center (Lucille P. Markey Cancer Center), Lexington

RecrutandoFase 2/3

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT06712316

Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

University of Kentucky/Markey Cancer Center, Lexington

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 17 de set. de 2026 · NCT06287775

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

CHI Saint Joseph Cancer Center - East, Lexington
University of Kentucky Chandler Medical Center, Lexington

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 8 de set. de 2026 · NCT06119581

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

Baptist Health Hardin Cancer Center, Elizabethtown

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 1 de set. de 2026 · NCT06712355

A Study of Pembrolizumab With or Without Chemotherapy in Combination With Additional Treatments for Advanced Non-Small Cell Lung Cancer (NSCLC) (MK-3475-01G/KEYMAKER U01)

University of Kentucky ( Site 0019), Lexington

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 18 de ago. de 2026 · NCT06731907

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

Xencor Investigative Site, Louisville

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 3 de ago. de 2026 · NCT05433142

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Norton Cancer Institute, Louisville

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 29 de jul. de 2026 · NCT04198766

Safety and Efficacy of OBX-115 in Advanced Solid Tumors

James Graham Brown Cancer Center (Melanoma/NSCLC), Louisville

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 16 de jul. de 2026 · NCT06060613

EXoPERT EMERALD Clinical Study

Lexington VA Healthcare System, Lexington
KCTL, Louisville

RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos

Idades 45 e acima · Todos os sexos · Atualizado em 1 de jul. de 2026 · NCT07186296

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

University of Louisville, Louisville

RecrutandoFase 2

Idades de 18 a 70 · Todos os sexos · Atualizado em 26 de jun. de 2026 · NCT04614103

A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

University of Louisville, Louisville

RecrutandoFase 1/2

Idades de 18 a 70 · Todos os sexos · Atualizado em 11 de jun. de 2026 · NCT05361174

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

University of Kentucky/Markey Cancer Center, Lexington

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 3 de jun. de 2026 · NCT05642572

Pathways, a Hope Intervention to Support Personal Goal Pursuit, Mental Health, and Quality of Life During Advanced Lung Cancer Treatment

University of Kentucky, Lexington

Recrutando

Idades 18 e acima · Todos os sexos · Atualizado em 8 de mai. de 2026 · NCT06047301

A Study of ZW251 in Participants With Advanced Solid Tumors

Norton Cancer Institute, Louisville

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 7 de mai. de 2026 · NCT07164313

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

University of Kentucky/Markey Cancer Center, Lexington

RecrutandoFase 2

18 Minutes · Todos os sexos · Atualizado em 5 de mai. de 2026 · NCT06031688

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

University of Kentucky/Markey Cancer Center, Lexington

RecrutandoFase 2/3

Idades 18 e acima · Todos os sexos · Atualizado em 5 de mai. de 2026 · NCT06616584

Precision Lung Cancer Survivorship Care Intervention

Markey Cancer Center, Lexington

Recrutando

Idades 18 e acima · Todos os sexos · Atualizado em 23 de fev. de 2026 · NCT05857995

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

University of Kentucky Markey Cancer Center, Lexington

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 13 de fev. de 2026 · NCT06778863

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Baptist Corbin, Corbin
Baptist Hardin, Elizabethtown
Baptist Lexington, Lexington

RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos

Idades 40 e acima · Todos os sexos · Atualizado em 20 de jan. de 2026 · NCT05366881

Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier

Lexington VA Health Care System, Lexington
Robley Rex VA Medical Center, Louisville

RecrutandoEstudo observacional

Idades de 29 a 85 · Todos os sexos · Atualizado em 13 de nov. de 2024 · NCT06426628

Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.